Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency

Blood (2021) 138 (15): 1304–1316.

https://doi.org/10.1182/blood.2020010260

Published: 2021

Includes: Supplemental data

Journal Articles

Lentiviral Gene Therapy with Autologous Hematopoietic Stem and Progenitor Cells (HSPCs) for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency (ADA-SCID): Results in an Expanded Cohort

Blood (2019) 134 (Supplement_1): 3345.

https://doi.org/10.1182/blood-2019-123432

Published: 2019

Journal Articles

Neutropenia Is an Under-Recognized Finding in Pediatric Primary Immunodeficiency Diseases: An Analysis of the United States Immunodeficiency Network Registry

Thomas F. Michniacki, MD, Kelly J. Walkovich, MD, Julie Sturza, MPH, Lauren E. Merz, BA, James Connelly, MD, Rebecca A. Marsh, David C Dale, MD, Elizabeth Garabedian, RN, MS

Blood (2018) 132 (Supplement 1): 3685.

https://doi.org/10.1182/blood-2018-99-113199

Published: 2018

Journal Articles

Early Transplant Improves Outcomes in Patients with Chronic Granulomatous Disease: Results from United States Immunodeficiency Network (USIDNET)

Jennifer Yonkof, MD, Ashish O. Gupta, MBBS,MPH, Pingfu Fu, Elizabeth Garabedian, RN, MS, Jignesh D Dalal, MD

Blood (2017) 130 (Supplement 1): 671.

https://doi.org/10.1182/blood.V130.Suppl_1.671.671

Published: 2017

Journal Articles

Cation Leak in Red Blood Cells of Patients with Wiskott-Aldrich Syndrome Leads to Non-Immunologic Hemolysis

Robert A. Sokolic, MD, Satheesh Chonat, MD, Mary Risinger, RN, Michael Eckhaus, DVM, Elizabeth Garabedian, RN, MSLS, Katherine R. Calvo, MD, PhD, Irina Maric, MD, Theodosia A. Kalfa, MD PhD, Fabio Candotti, MD

Blood (2014) 124 (21): 1338.

https://doi.org/10.1182/blood.V124.21.1338.1338

Published: 2014

Journal Articles

Gene therapy for adenosine deaminase–deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans

Blood (2012) 120 (18): 3635–3646.

https://doi.org/10.1182/blood-2012-02-400937

Published: 2012

Includes: Supplemental data

Journal Articles

Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency

Robert Sokolic, Irina Maric, Chimene Kesserwan, Elizabeth Garabedian, I. Celine Hanson, Margaret Dodds, Rebecca Buckley, Andrew C. Issekutz, Naynesh Kamani, Kit Shaw, Ben Tan, Pawan Bali, Michael S. Hershfield, Donald B. Kohn, Alan S. Wayne, Fabio Candotti

Blood (2011) 118 (10): 2688–2694.

https://doi.org/10.1182/blood-2011-01-329359

Published: 2011

Journal Articles

Reduced Number of Dense Bodies and Reduced Serotonin Content in Platelets of Patients with Wiskott-Aldrich Syndrome.

Robert A. Sokolic, Thomas Markello, Marcy Krumwiede, Roxanne Fischer, Elizabeth Garabedian, William A. Gahl, James G. White, Fabio Candotti

Blood (2009) 114 (22): 1321.

https://doi.org/10.1182/blood.V114.22.1321.1321

Published: 2009

Journal Articles

Dermatofibrosarcoma Protuberans in 3 Patients with ADA-SCID

Chimene Kesserwan, MD, Robert A. Sokolic, MD, Kerstin Heselmeyer, PhD, Clarymar Ortiz-Melendez, B.Sc, Jeffrey Cohen, MD, Jaya Jagadeesh, M.Sc, Elizabeth Garabedian, M.Sc, Kristin Baird, MD, Alan S. Wayne, MD, Edward W. Cowen, MD, Stefania Pittaluga, MD, PhD, Chyi-Chia Richard Lee, MD, PhD, Richard Sherry, MD, Julia Bridge, MD, Laura Finlayson, MD, Noreen Walsh, MD, Andrew Issekutz, MD, Fabio Candotti, MD

Blood (2008) 112 (11): 4833.

https://doi.org/10.1182/blood.V112.11.4833.4833

Published: 2008

Journal Articles

Comparative Results of Gene Therapy for Adenosine Deaminase Deficiency with or without PEG-ADA Withdrawal and Myelosuppressive Chemotherapy.

Robert Sokolic, MD, Greg Podsakoff, MD, Linda Muul, PhD, Barbara Engel, MD, Jayashree Jagadeesh, BS, Elizabeth Garabedian, RN, MSLS, Denise Carbonaro, Laura Tuschong, BS, Joanna Ireland, Michael Hershfield, MD, John Tisdale, MD, Cynthia Dunbar, MD, Alan Wayne, MD, Donald Kohn, MD, Fabio Candotti, MD

Blood (2007) 110 (11): 501.

https://doi.org/10.1182/blood.V110.11.501.501

Published: 2007

NARROW

Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency

Lentiviral Gene Therapy with Autologous Hematopoietic Stem and Progenitor Cells (HSPCs) for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency (ADA-SCID): Results in an Expanded Cohort

Neutropenia Is an Under-Recognized Finding in Pediatric Primary Immunodeficiency Diseases: An Analysis of the United States Immunodeficiency Network Registry

Early Transplant Improves Outcomes in Patients with Chronic Granulomatous Disease: Results from United States Immunodeficiency Network (USIDNET)

Cation Leak in Red Blood Cells of Patients with Wiskott-Aldrich Syndrome Leads to Non-Immunologic Hemolysis

Gene therapy for adenosine deaminase–deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans

Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency

Reduced Number of Dense Bodies and Reduced Serotonin Content in Platelets of Patients with Wiskott-Aldrich Syndrome.

Dermatofibrosarcoma Protuberans in 3 Patients with ADA-SCID

Comparative Results of Gene Therapy for Adenosine Deaminase Deficiency with or without PEG-ADA Withdrawal and Myelosuppressive Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only